dc.contributor.author | alobidy, Esraa fathi | |
dc.date.accessioned | 2020-07-07T10:21:15Z | |
dc.date.available | 2020-07-07T10:21:15Z | |
dc.date.issued | 2020-02-18 | |
dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/1746 | |
dc.description | The vast majority of the excitatory neurotransmission in the central nervous
system (CNS) is mediated by vesicular release of glutamate, which activates
both pre and postsynaptic G-protein–coupled metabotropic glutamate
receptors and ionotropic glutamate receptors (iGluRs). iGluRs are ligandgated cation channels that are divided into three major structurally distinct
functional classes: the α-amino-3-hydroxy-5-methyl-4-isoxasolepropionic
acid (AMPA) receptors, kainate receptors, and NMDA receptors | en_US |
dc.description.abstract | NMDA-type glutamate receptors are ligand-gated ion channels that mediate a
Ca2+-permeable component of excitatory neurotransmission in the central
nervous system (CNS). They are expressed throughout the CNS and play key
physiological roles in synaptic function, such as synaptic plasticity, learning,
and memory. NMDA receptors are also implicated in the pathophysiology of
several CNS disorders and more recently have been identified as a locus for
disease-associated genomic variation.NMDAR encephalitis is a common
cause of autoimmune encephalitis, predominantly affecting young adults.
Current data supports the idea that autoantibodies targeting NMDARs are
responsible for disease pathogenesis. While these autoantibodies occur in the
setting of underlying malignancy in approximately half of all patients,
initiating factors for the autoimmune response in the remainder of patients are
unclear Although the majority of patients achieve good outcomes. Common
clinical features include auditory and visual hallucinations, delusions,
behavioural change (frequently with agitation), impaired consciousness,
motor disturbance (ranging from dyskinesia to catatonia), seizures, and
autonomic dysfunction. for Further advances in our understanding of this
disease and underlying triggers are necessary to develop treatments which
improve outcomes | en_US |
dc.language.iso | en | en_US |
dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | Encephalitis Anti-N-Methyl-D-Aspartate Receptor Encephalitis | en_US |
dc.type | Other | en_US |